Prolemax 11.25mg Injection

Prolemax 11.25mg Injection contains the active ingredient Leuprolide acetate. It is a Gonadotropin-Releasing Hormone (GnRH) agonist. Prolemax 11.25mg Injection is prescribed for prostate cancer in men, hormone-responsive breast cancer, endometriosis (where tissue that normally lines the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used in treating premature puberty (central precocious puberty), a condition where a child's body begins to develop adult features earlier than expected due to abnormal hormonal release. Do not receive this injection if you are allergic to Leuprolide acetate or any other related ingredients, such as Goserelin and Triptorelin. Before receiving this medicine, inform your physician if you have liver or kidney impairment, or if you have undiagnosed abnormal uterine bleeding. This treatment should not be taken if you are pregnant or planning pregnancy. During therapy, existing symptoms may temporarily worsen because of increased sex steroid levels in the body. Speak to your physician about any concerns, and report immediately if your child has a progressive brain tumour. Before starting the treatment, notify your doctor if you have any underlying medical conditions, including diabetes, seizures, heart problems (chest pain or irregular heartbeat), depression, or osteoporosis (bone thinning risk). This medicine is not recommended in pregnant and breastfeeding women or in patients with abnormal vaginal bleeding. Women of childbearing age should use non-hormonal contraceptives during treatment with Prolemax 11.25mg Injection. Male patients should inform their doctor if they have urinary obstruction, have undergone testicle removal surgery, or experience spinal cord pressure, urinary problems, or haematuria (blood in urine). For patients seeking treatment and pricing details of similar hormone-related therapies, Aggramed injection is another prescribed option for certain conditions.

Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones).

Prolemax 11.25mg Injection decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Severe rash, itching Shortness or difficulty of breath Cough with blood Pulmonary embolism Severe headache Common Altered blood sugar and cholesterol levels Injection site reactions Loss of appetite Abnormal liver function Swelling in ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness.

Regular checkups every three months are recommended during breast cancer treatment with an aromatase inhibitor. Do not receive this injection if you experience abnormal vaginal bleeding. Consult your doctor immediately if you or your child has persistent headaches (even after using painkillers), vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Inform your doctor if you are still menstruating before starting the treatment.